SCARSELLI, GIANFRANCO
 Distribuzione geografica
Continente #
NA - Nord America 8.893
EU - Europa 8.288
AS - Asia 3.278
SA - Sud America 432
AF - Africa 102
OC - Oceania 78
Continente sconosciuto - Info sul continente non disponibili 43
Totale 21.114
Nazione #
US - Stati Uniti d'America 8.742
PL - Polonia 2.680
RU - Federazione Russa 1.862
IT - Italia 1.429
SG - Singapore 991
CN - Cina 726
SE - Svezia 594
HK - Hong Kong 503
IE - Irlanda 456
VN - Vietnam 384
BR - Brasile 337
DE - Germania 292
KR - Corea 255
UA - Ucraina 233
FR - Francia 223
FI - Finlandia 204
GB - Regno Unito 112
CA - Canada 103
IN - India 99
NL - Olanda 91
AU - Australia 76
JO - Giordania 61
TR - Turchia 59
CH - Svizzera 48
AR - Argentina 34
ID - Indonesia 29
IQ - Iraq 26
JP - Giappone 25
NG - Nigeria 24
BD - Bangladesh 22
EC - Ecuador 19
MX - Messico 19
ES - Italia 18
PK - Pakistan 16
CI - Costa d'Avorio 15
CL - Cile 12
MA - Marocco 11
SC - Seychelles 11
ZA - Sudafrica 11
NP - Nepal 10
PE - Perù 9
AT - Austria 8
KE - Kenya 8
LT - Lituania 8
UZ - Uzbekistan 8
AZ - Azerbaigian 7
MY - Malesia 7
VE - Venezuela 7
AE - Emirati Arabi Uniti 6
BE - Belgio 6
CO - Colombia 6
OM - Oman 6
SA - Arabia Saudita 6
CR - Costa Rica 5
CZ - Repubblica Ceca 5
EG - Egitto 5
GT - Guatemala 5
IR - Iran 5
BG - Bulgaria 4
HN - Honduras 4
IL - Israele 4
JM - Giamaica 4
KZ - Kazakistan 4
PY - Paraguay 4
BN - Brunei Darussalam 3
BY - Bielorussia 3
BZ - Belize 3
PH - Filippine 3
PS - Palestinian Territory 3
PT - Portogallo 3
TG - Togo 3
TH - Thailandia 3
TN - Tunisia 3
UY - Uruguay 3
AL - Albania 2
BB - Barbados 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
EU - Europa 2
KG - Kirghizistan 2
MU - Mauritius 2
MW - Malawi 2
NO - Norvegia 2
SN - Senegal 2
SV - El Salvador 2
AM - Armenia 1
CW - ???statistics.table.value.countryCode.CW??? 1
DZ - Algeria 1
EE - Estonia 1
GA - Gabon 1
GE - Georgia 1
GH - Ghana 1
GR - Grecia 1
GY - Guiana 1
KI - Kiribati 1
LB - Libano 1
LV - Lettonia 1
MD - Moldavia 1
MK - Macedonia 1
MN - Mongolia 1
Totale 21.070
Città #
Warsaw 2.674
Santa Clara 1.847
Ashburn 729
Singapore 687
Chandler 592
Fairfield 494
Dublin 456
Jacksonville 417
Hong Kong 390
Woodbridge 268
Seattle 250
Seoul 250
Cambridge 242
Milan 224
Wilmington 203
Houston 198
Beijing 194
San Jose 183
Council Bluffs 172
Los Angeles 156
Buffalo 140
Princeton 120
Rome 118
The Dalles 112
Ho Chi Minh City 107
Lauterbourg 106
New York 103
Dallas 96
Boardman 85
Boston 84
Munich 81
Hanoi 78
Ann Arbor 76
Hefei 75
Melbourne 74
Paris 74
Florence 73
Helsinki 71
Lawrence 70
Mumbai 67
Altamura 64
Amsterdam 64
Medford 62
Shanghai 52
Naples 51
Bern 47
Izmir 45
Orem 42
Moscow 41
San Diego 41
Denver 37
Turin 34
São Paulo 32
Toronto 30
Atlanta 29
Kent 29
Montreal 29
Dong Ket 28
Brooklyn 27
Bologna 24
Chicago 24
San Francisco 24
Abuja 23
Norwalk 23
Phoenix 23
Tokyo 22
Jakarta 21
Palermo 21
Columbus 20
Guangzhou 18
Frankfurt am Main 17
Haiphong 17
Turku 16
Verona 16
Abidjan 15
Brescia 15
Bari 14
Genoa 14
Miami 14
Belo Horizonte 13
Stockholm 13
Figino 12
Redondo Beach 12
Rio de Janeiro 12
Da Nang 11
Figline Valdarno 11
Hillsboro 11
Salerno 11
Tianjin 11
Falls Church 10
Minneapolis 10
Philadelphia 10
Amman 9
Venice 9
Andover 8
Auburn Hills 8
Bremen 8
Curitiba 8
Guayaquil 8
Livorno 8
Totale 13.814
Nome #
PRESSURE LAVAGE UNDER ULTRASOUND GUIDANCE: A NEW APPROACH FOR OUTPATIENT TREATMENT OF INTRAUTERINE ADHESION 989
Analoghi del GnRH: agonisti e antagonisti 590
UTILIZZAZIONE DI UN DISPOSITIVO INTRAUTERINO CHE RILASCIA PROGESTERONE (PROGESTASERT) : INDICAZIONI E PROSPETTIVE 362
COX-2, c-KIT and HER-2/neu expression in uterine carcinosarcomas: prognostic factors or potential markers for targeted therapies? 344
A sperm survival test and in-vitro fertilization outcome in the presence of male factor infertility 304
Hypercoagulability, high tissue factor and low tissue factor pathway inhibitor levels in severe ovarian hyperstimulation syndrome: possible association with clinical outcome. 303
Ovarian surgery for bilateral endometriomas influences age at menopause. 300
Riproduzione medica assistita ed endometriosi. 299
Approccio multidisciplinare all’endometriosi severa: aspetti diagnostici e terapeutici. 291
Acute abdomen following dermoid cyst rupture during transvaginal ultrasonographically guided retrieval of oocytes 289
Long-term follow-up after laparoscopic treatment for endometriosis: multivariate analysis of predictive factors for recurrence of endometriotic lesions and pain. 279
COMPLEX PELVIC MASS AS A TARGET OF EVALUATION OF VESSEL DISTRIBUTION BY COLOR DOPPLER SONOGRAPHY FOR THE DIAGNOSIS OF ADNEXAL MALIGNANCIES: RESULTS OF A MULTICENTER EUROPEAN STUDY 278
Endometriosis and Pain in an Adolescent population 276
GNRH ANTAGONISTS 275
Luteinizing hormone increases human endometrial cancer cells invasiveness through activation of protein kinase A. 274
Masse annessiali 272
The effect of the hormonal milieu of pregnancy on deep infiltrating endometriosis: serial ultrasound assessment of changes in size and pattern of deep endometriotic lesions. 269
Diagnosis and treatment of endometriosis. A review 266
Seven-liter ovarian cyst in an adolescent treated by minimal access surgery: laparoscopy and open cystectomy. 255
Clinical, ethical, and medical legal considerations on emergency contraception 253
hLH/hCG-receptor expression correlates with in vitro invasiveness in human primary endometrial cancer 243
Fetal and neonatal ovarian cysts: what's their real meaning? 222
PREMATURE OVARIAN FAILURE AND FRAGILE X PREMUTATION: A STUDY ON 45 WOMEN 210
Analysis of estrogen receptor (ERalpha and ERbeta and progesterone receptor (PR) polymorphisms in uterine leiomyomas. 206
Abnormal production of T helper 2 cytokines interleukin-4 and interleukin-5 by T cells from newborns with atopic parents. 204
Preoperative assessment of HER-2/neu status in breast carcinoma: The role of quantitative real-time PCR on core-biopsy specimens 202
ANALYSIS OF ESTROGEN RECEPTOR (ER-ALPHA AND ER-BETA) AND PROGESTERONE RECEPTOR (PR) POLYMORPHISMS IN UTERINE LEIOMYOMAS 200
Over-Expression of the LH Receptor Increases Distant Metastases in an Endometrial Cancer Mouse Model. 198
Feasibility of myomectomy performed by minilaparotomy. 194
Clinical utility of liquid-based cytology for the characterization and management of endometrial polyps in postmenopausal age. 194
Axillary ultrasound scanning in the follow-up of breast cancer patients undergoing sentinel node biopsy. 193
COX-2, c-KIT and HER-2/neu expression in uterine carcinosarcomas: prognostic factors or potential markers for targeted therapies? 192
Cross-sectional and longitudinal evaluation of uterine artery Doppler velocimetry for the prediction of pre-eclampsia in normotensive women with specific risk factors 190
Levonorgestrel-releasing intrauterine system alone as primary treatment in young women with early endometrial cancer: case report. 190
Levonorgestrel-releasing intrauterine system (LNG-IUS) as an effective treatment option for endometrial hyperplasia: a 15-year follow-up study. 188
CAN HYSTEROSCOPIC EVALUATION OF ENDOMETRIAL CARCINOMA INFLUENCE THE THERAPEUTIC TREATMENT? 184
Axillary ultrasound scanning in the follow up of breast cancer patients submitted to sentinel node biopsy. 183
Can hysteroscopic evaluation of endometrial carcinoma influence therapeutic treatment? 181
Fertilisation and implantation failure in an oral contraceptive user. 178
Low day 3 luteinizing hormone values are predictive of reduced response to ovarian stimulation. 176
Carbon-dioxide laser vaporization of the Bartholin gland cyst: a retrospective analysis on 200 cases. 176
Comparison of two techniques for transcervical cell sampling performed in the same study population. 175
LA TERAPIA DEL LICHEN SCLEROSO DELLA VULVA 174
ENDOMETRIAL EVALUATION WITH TRANSVAGINAL ULTRASOUND DURING HORMONE THERAPY: A PROSPECTIVE MULTICENTER STUDY 172
Radiofrequency Ablation for Minimally Invasive Treatment of Breast Carcinoma. A Pilot Study in Elderly Inoperable Patients. 171
TRATTAMENTO PROGESTINICO LOCALE DELLA IPERPLASIA ENDOMETRIALE 171
Effects of progesterone on human spermatozoa: clinical implications. 170
Expression and amplification of HER-2/neu oncogene in uterine carcinosarcomas: a marker for potential molecularly targeted treatment? 170
Perinatal care at an extremely low gestational age (22-25 weeks). An Italian approach: the "Carta di Firenze". 168
FERTILISATION AND IMPLANTATION FAILURE IN ORAL CONTRACEPTIVE USER 167
Laser CO2 conization in postmenopausal age: risk of cervical stenosis and unsatisfactory follow-up. 167
Vaginal hysterectomy and abdominal hysterectomy for treatment of endometrial cancer in the elderly 165
Iter diagnostico nel sanguinamento uterino anomalo: stato dell’arte, esperienza personale e proposta di approccio diagnostico. 162
Approccio terapeutico nella paziente obesa affetta da carcinoma dell’endometrio. 155
LA CARATTERIZZAZIONE ISTOPATOLOGICA DEI CARCINOMA DELL'OVAIO 154
Surveillance for endometrial cancer in women on tamoxifen: the role of liquid-based endometrial cytology - cytohistological correlation in a population of 168 women. 152
Reproductive performance before and after abdominal myomectomy: a retrospective analysis. 150
Comparison of the number of uterine myomas detected by in-office transvaginal ultrasonography removed by laparotomic myomectomy: preoperative work-up concerns. 148
CO2 laser cylindrical excision or standard re-conization for persistent-recurrent high-grade cervical intraepithelial neoplasia (HG-CIN) in women of fertile age. 147
Non-classic sHLA class I in human oocyte culture medium. 147
Comparative pharmacokinetic evaluation of ceftriaxone and cefotaxime in coincidence for short-term antimicrobial prophylaxis in surgery 147
Clinico-pathological profile of endometrial carcinoma in young women (under 40years of age). 146
I TUMORI EPITELIALI OVARICI A BASSO POTENZIALE DI MALIGNITA' 146
Feasibility and outcome of laser CO2 conization performed within the 18th week of gestation. 145
Ten-year results of a prospective study on the prognostic role of ploidy in endometrial carcinoma: DNA aneuploidy identifies high-risk cases among the so-called 'low-risk' patients with well and moderately differentiated tumors. 145
Miomectomia minilaparotomica 145
Applicazioni cliniche della citologia endometriale in fase clinica. 145
PCR detection rates of high risk human papillomavirus DNA in paired self-collected urine and cervical scrapes after laser CO2 conization for high-grade cervical intraepithelial neoplasia. 144
DNA ploidy is stronger than lymph node metastasis as prognostic factor in cervical carcinoma: 10-year results of a prospective study 143
Mini-laparotomy versus vaginal surgery for class II-III obese patients with early-stage endometrial cancer. 142
Ovarian cancer in the elderly: feasibility of surgery and chemotherapy in 89 geriatric patients. 142
La nuova stadiazione FIGO per i tumori uterini: cosa è cambiato e perchè 142
Liquid-based endometrial cytology: its possible value in postmenopausal asymptomatic women. 139
ENDOMETRIAL PATTERNS DURING ORAL CONTRACEPTION WITH DESOGESTREL 139
Screening for microdeletions of Y chromosome genes in patients undergoing intracytoplasmic sperm injection. 138
Enzymes of human cervical mucus: a comparative study on fertile and infertile mucus and on the endocervical epithelium 137
Endometriosis and infertility Surgery and ART: An integrated approach for successful management 137
Perioperative chemotherapy in thet reatment of carcinoma of the uterine cervix 137
Polychemotherapy in ovarian cancer: treatment with adriamycin, BCNU and cyclophosphamide vs. adrianycin and cyclophosphamide 135
Post conception failures in reproduction: infectious diseases and immunitary problems. 135
Laser conizzazione cervicale in età fertile e postmenopausica. 135
Effetti protettivi e rischi della contraccezione ormonale sui tumori. Utero e Cervice. 135
Oral medroxyprogesterone acetate pharmacokinetics: results in a group of patients during a controlled clinical trial on stage I endometrial carcinoma. 134
FATTORI PROGNOSTICI DEL CARCINOMA DELLA VULVA PER UNA TERAPIA PERSONALIZZATA 134
Perinatal care at extremely low gestational age (22-25 weeks). An Italian approach: the "Carta di Firenze". 134
Cone: its possible diagnostic and therapeutical role in microcarcinoma. 129
UTILITA' DELLA TERAPIA CON HCG NEI CASI DI INSUFFICIENZA LUTEINICA 126
Precancerous lesions of the endometrium and medical treatment. 126
Large-muscle endometriosis involving theadductor tight compartment: case report. 126
IL CARCINOMA ENDOMETRIALE NELLE DONNE DI ETA' INFERIORE O UGUALE A 40 ANNI.STUDIO CLINICO-PATOLOGICO 125
Macroscopic evidence of ectopic pregnancy associated with mechanical tubal obstruction. 122
Levo-norgestrel-nova-T and precancerous lesions of the endometrium. 121
Prenatal diagnosis of common aneuploidies in transcervical samples using quantitative fluorescent-PCR analysis. 121
Method of delivery and intraventricular hemorrhage in extremely preterm infants 119
Usefulness of hysteroscopy in endometrial adenocarcinoma staging. 119
RISCHIO ONCOGENO ENDOMETRIALE E MENOPAUSA: UTILITA' DELL'ISTEROSCOPIA DIAGNOSTICA 119
Regulation of fetal allograft survival by hormone-controlled T cell cytokines 118
Morphological and functional aspects of the endometrium of asymptomatic post-menopausal women: does the endometrium really age? 117
Tamoxifen, endometrial cancer risk and liquid based cytology. A paradigmatic case 116
Defective production of both leukemia inhibitory factor and type 2 T-helper cytokines by decidual T cells in unexplained recurrent abortions 114
Totale 19.276
Categoria #
all - tutte 51.770
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.770


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022718 0 114 31 32 24 14 21 46 36 23 175 202
2022/20232.146 199 269 92 202 185 388 276 126 248 18 72 71
2023/2024864 67 92 137 51 48 100 53 189 3 37 38 49
2024/20255.171 185 534 355 807 1.647 658 57 256 178 185 167 142
2025/20265.693 561 697 268 282 603 206 677 235 337 324 867 636
2026/2027307 147 160 0 0 0 0 0 0 0 0 0 0
Totale 21.114